Immunological responses and clinical outcomes in pet dogs with osteosarcoma receiving standard of care therapy and a recombinant Listeria vaccine expressing HER2/neu.

• Tác giả: C E Balkman, L Barber, J A Beck, J N Bryan, J H Burton, A Cherukuri, K M Curran, N Dervisis, B Flesner, P R Hess, M L Higginbotham, W C Kisseberth, A K LeBlanc, H Leeper, C A London, V S MacDonald-Dickinson, J Mahoney, Nicola J Mason, C Mazcko, A L McCleary-Wheeler, A J Mutsaers, S Patkar, J A Perry, A Rotolo, Audrey Ruple, C Saba, Laura Selmic, D M Vail, K Weishaar, J L Willcox, H Wilson-Robles, J P Woods, R M Wouda
• Ngôn ngữ: eng
• Thông tin xuất bản: United States : Molecular therapy : the journal of the American Society of Gene Therapy , 2025
• Bộ sưu tập: NCBI
• ID: 148675

Tóm tắt

A clinical trial in dogs with spontaneous osteosarcoma was performed to assess a recombinant Listeria expressing a chimeric human HER2/neu (ADXS31-164